Clinical trial
A Randomized, Open Label, Multicenter, Phase 4 Study for the Comparison of Efficacy of Tiotropium Plus Salmeterol/ Fluticasone Propionate Compared With Tiotropium Alone in COPD Patients
NCT00864812 is registered in ClinicalTrials.gov with The Korean Academy of Tuberculosis and Respiratory Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Open Label, Multicenter, Phase 4 Study for the Comparison of Efficacy of Tiotropium Plus Salmeterol/ Fluticasone Propionate Compared With Tiotropium Alone in COPD Patients
- Lead sponsor
- The Korean Academy of Tuberculosis and Respiratory Diseases
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2009
- Completion date
- March 31, 2010
- Enrollment
- 509 (actual)
- Sites
- 32
Conditions
As the registry lists them; a condition with its own page is linked.
chronic obstructive pulmonary disease